nodes	percent_of_prediction	percent_of_DWPC	metapath
Fluorouracil—Nucleic Acid Synthesis Inhibitors—Capecitabine—kidney cancer	0.181	0.5	CiPCiCtD
Fluorouracil—Nucleic Acid Synthesis Inhibitors—Gemcitabine—kidney cancer	0.181	0.5	CiPCiCtD
Fluorouracil—PPAT—kidney cancer	0.158	1	CbGaD
Fluorouracil—urinary bladder cancer—kidney cancer	0.114	0.541	CtDrD
Fluorouracil—pancreatic cancer—kidney cancer	0.0965	0.458	CtDrD
Fluorouracil—DPYD—Capecitabine—kidney cancer	0.0532	0.287	CbGbCtD
Fluorouracil—TYMP—Capecitabine—kidney cancer	0.0353	0.191	CbGbCtD
Fluorouracil—TYMS—Capecitabine—kidney cancer	0.0188	0.101	CbGbCtD
Fluorouracil—SLC29A1—Gemcitabine—kidney cancer	0.0141	0.0759	CbGbCtD
Fluorouracil—TYMS—Gemcitabine—kidney cancer	0.013	0.0703	CbGbCtD
Fluorouracil—ABCC3—Vincristine—kidney cancer	0.00526	0.0284	CbGbCtD
Fluorouracil—ABCC4—Sorafenib—kidney cancer	0.00414	0.0223	CbGbCtD
Fluorouracil—ABCG2—Pazopanib—kidney cancer	0.00384	0.0207	CbGbCtD
Fluorouracil—ABCG2—Dactinomycin—kidney cancer	0.00351	0.0189	CbGbCtD
Fluorouracil—ABCC4—Sunitinib—kidney cancer	0.00336	0.0181	CbGbCtD
Fluorouracil—ABCC3—Doxorubicin—kidney cancer	0.00329	0.0177	CbGbCtD
Fluorouracil—ABCG2—Erlotinib—kidney cancer	0.00274	0.0148	CbGbCtD
Fluorouracil—ABCG2—Paclitaxel—kidney cancer	0.00251	0.0135	CbGbCtD
Fluorouracil—ABCG2—Sorafenib—kidney cancer	0.00223	0.012	CbGbCtD
Fluorouracil—ABCG2—Vincristine—kidney cancer	0.00216	0.0117	CbGbCtD
Fluorouracil—CYP2C8—Pazopanib—kidney cancer	0.00205	0.011	CbGbCtD
Fluorouracil—ALB—Erlotinib—kidney cancer	0.00189	0.0102	CbGbCtD
Fluorouracil—ABCG2—Sunitinib—kidney cancer	0.00181	0.00974	CbGbCtD
Fluorouracil—CYP1A2—Pazopanib—kidney cancer	0.00158	0.00854	CbGbCtD
Fluorouracil—CYP2C9—Capecitabine—kidney cancer	0.00149	0.00803	CbGbCtD
Fluorouracil—CYP2C8—Erlotinib—kidney cancer	0.00146	0.00787	CbGbCtD
Fluorouracil—ABCG2—Doxorubicin—kidney cancer	0.00135	0.00729	CbGbCtD
Fluorouracil—CYP2C8—Paclitaxel—kidney cancer	0.00134	0.00721	CbGbCtD
Fluorouracil—CYP2C8—Sorafenib—kidney cancer	0.00119	0.0064	CbGbCtD
Fluorouracil—UPP2—renal system—kidney cancer	0.00118	0.0812	CbGeAlD
Fluorouracil—UPP2—kidney—kidney cancer	0.00114	0.0785	CbGeAlD
Fluorouracil—CYP1A2—Erlotinib—kidney cancer	0.00113	0.0061	CbGbCtD
Fluorouracil—UPP2—cortex of kidney—kidney cancer	0.00111	0.0764	CbGeAlD
Fluorouracil—CYP2C9—Paclitaxel—kidney cancer	0.000932	0.00503	CbGbCtD
Fluorouracil—CYP1A2—Sorafenib—kidney cancer	0.000919	0.00496	CbGbCtD
Fluorouracil—CYP2C9—Sorafenib—kidney cancer	0.000828	0.00447	CbGbCtD
Fluorouracil—UMPS—nephron tubule—kidney cancer	0.000736	0.0506	CbGeAlD
Fluorouracil—UPP1—nephron tubule—kidney cancer	0.000675	0.0464	CbGeAlD
Fluorouracil—UMPS—cortex of kidney—kidney cancer	0.00063	0.0433	CbGeAlD
Fluorouracil—UPP1—cortex of kidney—kidney cancer	0.000578	0.0397	CbGeAlD
Fluorouracil—UPP1—cardiac atrium—kidney cancer	0.00055	0.0378	CbGeAlD
Fluorouracil—DPYD—nephron tubule—kidney cancer	0.000548	0.0377	CbGeAlD
Fluorouracil—DPYD—cortex of kidney—kidney cancer	0.000469	0.0323	CbGeAlD
Fluorouracil—CYP1A2—urine—kidney cancer	0.000466	0.032	CbGeAlD
Fluorouracil—DPYD—cardiac atrium—kidney cancer	0.000446	0.0307	CbGeAlD
Fluorouracil—CYP2C9—urine—kidney cancer	0.000442	0.0304	CbGeAlD
Fluorouracil—PPAT—gonad—kidney cancer	0.000387	0.0266	CbGeAlD
Fluorouracil—SLC22A7—renal system—kidney cancer	0.000288	0.0198	CbGeAlD
Fluorouracil—SLC22A7—kidney—kidney cancer	0.000278	0.0191	CbGeAlD
Fluorouracil—TYMS—nephron tubule—kidney cancer	0.000272	0.0187	CbGeAlD
Fluorouracil—TYMP—cortex of kidney—kidney cancer	0.000272	0.0187	CbGeAlD
Fluorouracil—SLC22A7—cortex of kidney—kidney cancer	0.000271	0.0186	CbGeAlD
Fluorouracil—ABCC5—nephron tubule—kidney cancer	0.000266	0.0183	CbGeAlD
Fluorouracil—TYMP—cardiac atrium—kidney cancer	0.000259	0.0178	CbGeAlD
Fluorouracil—TYMS—cortex of kidney—kidney cancer	0.000233	0.016	CbGeAlD
Fluorouracil—SLC29A1—renal system—kidney cancer	0.000222	0.0153	CbGeAlD
Fluorouracil—TYMS—gonad—kidney cancer	0.000222	0.0153	CbGeAlD
Fluorouracil—ABCC5—cardiac atrium—kidney cancer	0.000217	0.0149	CbGeAlD
Fluorouracil—SLC29A1—kidney—kidney cancer	0.000215	0.0148	CbGeAlD
Fluorouracil—SLC29A1—cortex of kidney—kidney cancer	0.000209	0.0144	CbGeAlD
Fluorouracil—ABCC3—renal system—kidney cancer	0.000203	0.014	CbGeAlD
Fluorouracil—SLC29A1—gonad—kidney cancer	0.000199	0.0137	CbGeAlD
Fluorouracil—SLC29A1—cardiac atrium—kidney cancer	0.000199	0.0137	CbGeAlD
Fluorouracil—ABCC3—kidney—kidney cancer	0.000196	0.0135	CbGeAlD
Fluorouracil—ABCC4—nephron tubule—kidney cancer	0.000184	0.0127	CbGeAlD
Fluorouracil—ABCC4—renal system—kidney cancer	0.000168	0.0115	CbGeAlD
Fluorouracil—ABCC4—kidney—kidney cancer	0.000162	0.0112	CbGeAlD
Fluorouracil—ABCC4—cortex of kidney—kidney cancer	0.000158	0.0109	CbGeAlD
Fluorouracil—PPAT—Sirolimus—Everolimus—kidney cancer	0.000137	0.117	CbGdCrCtD
Fluorouracil—PPAT—Sirolimus—Temsirolimus—kidney cancer	0.000137	0.117	CbGdCrCtD
Fluorouracil—PPAT—Temsirolimus—Everolimus—kidney cancer	0.000137	0.117	CbGdCrCtD
Fluorouracil—ABCG2—nephron tubule—kidney cancer	0.00013	0.00896	CbGeAlD
Fluorouracil—UMPS—Sirolimus—Temsirolimus—kidney cancer	0.000129	0.11	CbGdCrCtD
Fluorouracil—UMPS—Sirolimus—Everolimus—kidney cancer	0.000129	0.11	CbGdCrCtD
Fluorouracil—UMPS—Everolimus—Temsirolimus—kidney cancer	0.000129	0.11	CbGdCrCtD
Fluorouracil—CYP2C8—renal system—kidney cancer	0.000122	0.00838	CbGeAlD
Fluorouracil—CYP2C8—kidney—kidney cancer	0.000118	0.0081	CbGeAlD
Fluorouracil—CYP1A2—renal system—kidney cancer	0.000114	0.00784	CbGeAlD
Fluorouracil—TYMS—Docetaxel—Paclitaxel—kidney cancer	6.7e-05	0.0573	CbGdCrCtD
Fluorouracil—UMPS—Daunorubicin—Doxorubicin—kidney cancer	4.14e-05	0.0355	CbGdCrCtD
Fluorouracil—UMPS—Epirubicin—Doxorubicin—kidney cancer	4.14e-05	0.0355	CbGdCrCtD
Fluorouracil—UMPS—Idarubicin—Doxorubicin—kidney cancer	4.14e-05	0.0355	CbGdCrCtD
Fluorouracil—TYMS—Sirolimus—Everolimus—kidney cancer	3.22e-05	0.0275	CbGdCrCtD
Fluorouracil—TYMS—Sirolimus—Temsirolimus—kidney cancer	3.22e-05	0.0275	CbGdCrCtD
Fluorouracil—TYMS—Gefitinib—Erlotinib—kidney cancer	3.21e-05	0.0275	CbGdCrCtD
Fluorouracil—Alopecia—Paclitaxel—kidney cancer	2.63e-05	0.000621	CcSEcCtD
Fluorouracil—Thrombophlebitis—Doxorubicin—kidney cancer	2.63e-05	0.000621	CcSEcCtD
Fluorouracil—Nervous system disorder—Vincristine—kidney cancer	2.61e-05	0.000616	CcSEcCtD
Fluorouracil—Thrombocytopenia—Vincristine—kidney cancer	2.6e-05	0.000615	CcSEcCtD
Fluorouracil—Discomfort—Gemcitabine—kidney cancer	2.6e-05	0.000614	CcSEcCtD
Fluorouracil—Urticaria—Sorafenib—kidney cancer	2.6e-05	0.000613	CcSEcCtD
Fluorouracil—Photosensitivity—Doxorubicin—kidney cancer	2.59e-05	0.000612	CcSEcCtD
Fluorouracil—Erythema—Paclitaxel—kidney cancer	2.59e-05	0.000612	CcSEcCtD
Fluorouracil—Decreased appetite—Dactinomycin—kidney cancer	2.59e-05	0.000611	CcSEcCtD
Fluorouracil—Diarrhoea—Vinblastine—kidney cancer	2.59e-05	0.000611	CcSEcCtD
Fluorouracil—Body temperature increased—Sorafenib—kidney cancer	2.58e-05	0.00061	CcSEcCtD
Fluorouracil—Diarrhoea—Everolimus—kidney cancer	2.58e-05	0.000609	CcSEcCtD
Fluorouracil—Pruritus—Erlotinib—kidney cancer	2.57e-05	0.000607	CcSEcCtD
Fluorouracil—Epistaxis—Capecitabine—kidney cancer	2.56e-05	0.000606	CcSEcCtD
Fluorouracil—Pain—Dactinomycin—kidney cancer	2.55e-05	0.000601	CcSEcCtD
Fluorouracil—Agranulocytosis—Capecitabine—kidney cancer	2.54e-05	0.000599	CcSEcCtD
Fluorouracil—Anorexia—Vincristine—kidney cancer	2.54e-05	0.000599	CcSEcCtD
Fluorouracil—Oedema—Gemcitabine—kidney cancer	2.52e-05	0.000596	CcSEcCtD
Fluorouracil—Anaphylactic shock—Gemcitabine—kidney cancer	2.52e-05	0.000596	CcSEcCtD
Fluorouracil—Infection—Gemcitabine—kidney cancer	2.51e-05	0.000592	CcSEcCtD
Fluorouracil—Dizziness—Vinblastine—kidney cancer	2.5e-05	0.00059	CcSEcCtD
Fluorouracil—Dizziness—Everolimus—kidney cancer	2.49e-05	0.000588	CcSEcCtD
Fluorouracil—Body temperature increased—Sunitinib—kidney cancer	2.49e-05	0.000587	CcSEcCtD
Fluorouracil—Diarrhoea—Erlotinib—kidney cancer	2.49e-05	0.000587	CcSEcCtD
Fluorouracil—Hypotension—Vincristine—kidney cancer	2.49e-05	0.000587	CcSEcCtD
Fluorouracil—Nervous system disorder—Gemcitabine—kidney cancer	2.47e-05	0.000585	CcSEcCtD
Fluorouracil—Thrombocytopenia—Gemcitabine—kidney cancer	2.47e-05	0.000584	CcSEcCtD
Fluorouracil—Feeling abnormal—Dactinomycin—kidney cancer	2.45e-05	0.00058	CcSEcCtD
Fluorouracil—Haemoglobin—Capecitabine—kidney cancer	2.45e-05	0.000579	CcSEcCtD
Fluorouracil—Rhinitis—Capecitabine—kidney cancer	2.45e-05	0.000578	CcSEcCtD
Fluorouracil—Haemorrhage—Capecitabine—kidney cancer	2.44e-05	0.000576	CcSEcCtD
Fluorouracil—Vision blurred—Paclitaxel—kidney cancer	2.44e-05	0.000576	CcSEcCtD
Fluorouracil—Hypoaesthesia—Capecitabine—kidney cancer	2.43e-05	0.000574	CcSEcCtD
Fluorouracil—Musculoskeletal discomfort—Vincristine—kidney cancer	2.42e-05	0.000572	CcSEcCtD
Fluorouracil—Pharyngitis—Capecitabine—kidney cancer	2.42e-05	0.000572	CcSEcCtD
Fluorouracil—Hypersensitivity—Sorafenib—kidney cancer	2.41e-05	0.000569	CcSEcCtD
Fluorouracil—Insomnia—Vincristine—kidney cancer	2.41e-05	0.000568	CcSEcCtD
Fluorouracil—Anorexia—Gemcitabine—kidney cancer	2.41e-05	0.000568	CcSEcCtD
Fluorouracil—Vomiting—Vinblastine—kidney cancer	2.4e-05	0.000568	CcSEcCtD
Fluorouracil—Dizziness—Erlotinib—kidney cancer	2.4e-05	0.000567	CcSEcCtD
Fluorouracil—Vomiting—Everolimus—kidney cancer	2.39e-05	0.000566	CcSEcCtD
Fluorouracil—Anaemia—Paclitaxel—kidney cancer	2.39e-05	0.000565	CcSEcCtD
Fluorouracil—Paraesthesia—Vincristine—kidney cancer	2.39e-05	0.000564	CcSEcCtD
Fluorouracil—Dermatitis bullous—Doxorubicin—kidney cancer	2.38e-05	0.000562	CcSEcCtD
Fluorouracil—Rash—Everolimus—kidney cancer	2.37e-05	0.000561	CcSEcCtD
Fluorouracil—Dermatitis—Everolimus—kidney cancer	2.37e-05	0.00056	CcSEcCtD
Fluorouracil—Headache—Vinblastine—kidney cancer	2.37e-05	0.000559	CcSEcCtD
Fluorouracil—Headache—Everolimus—kidney cancer	2.36e-05	0.000557	CcSEcCtD
Fluorouracil—Hypotension—Gemcitabine—kidney cancer	2.36e-05	0.000557	CcSEcCtD
Fluorouracil—Body temperature increased—Dactinomycin—kidney cancer	2.35e-05	0.000556	CcSEcCtD
Fluorouracil—Cardiac failure—Doxorubicin—kidney cancer	2.33e-05	0.00055	CcSEcCtD
Fluorouracil—Lethargy—Doxorubicin—kidney cancer	2.32e-05	0.000548	CcSEcCtD
Fluorouracil—Leukopenia—Paclitaxel—kidney cancer	2.32e-05	0.000547	CcSEcCtD
Fluorouracil—Hypersensitivity—Sunitinib—kidney cancer	2.32e-05	0.000547	CcSEcCtD
Fluorouracil—Decreased appetite—Vincristine—kidney cancer	2.31e-05	0.000546	CcSEcCtD
Fluorouracil—Pruritus—Sorafenib—kidney cancer	2.31e-05	0.000546	CcSEcCtD
Fluorouracil—Vomiting—Erlotinib—kidney cancer	2.31e-05	0.000546	CcSEcCtD
Fluorouracil—Musculoskeletal discomfort—Gemcitabine—kidney cancer	2.3e-05	0.000543	CcSEcCtD
Fluorouracil—Gastrointestinal disorder—Vincristine—kidney cancer	2.3e-05	0.000542	CcSEcCtD
Fluorouracil—Rash—Erlotinib—kidney cancer	2.29e-05	0.000541	CcSEcCtD
Fluorouracil—Dermatitis—Erlotinib—kidney cancer	2.29e-05	0.000541	CcSEcCtD
Fluorouracil—Insomnia—Gemcitabine—kidney cancer	2.28e-05	0.000539	CcSEcCtD
Fluorouracil—Headache—Erlotinib—kidney cancer	2.28e-05	0.000538	CcSEcCtD
Fluorouracil—Pain—Vincristine—kidney cancer	2.27e-05	0.000537	CcSEcCtD
Fluorouracil—Osteoarthritis—Doxorubicin—kidney cancer	2.27e-05	0.000537	CcSEcCtD
Fluorouracil—Gastrointestinal haemorrhage—Doxorubicin—kidney cancer	2.27e-05	0.000537	CcSEcCtD
Fluorouracil—Paraesthesia—Gemcitabine—kidney cancer	2.27e-05	0.000535	CcSEcCtD
Fluorouracil—Dyspnoea—Gemcitabine—kidney cancer	2.25e-05	0.000531	CcSEcCtD
Fluorouracil—Nausea—Vinblastine—kidney cancer	2.24e-05	0.00053	CcSEcCtD
Fluorouracil—Somnolence—Gemcitabine—kidney cancer	2.24e-05	0.00053	CcSEcCtD
Fluorouracil—Convulsion—Paclitaxel—kidney cancer	2.24e-05	0.00053	CcSEcCtD
Fluorouracil—Nausea—Everolimus—kidney cancer	2.24e-05	0.000528	CcSEcCtD
Fluorouracil—Diarrhoea—Sorafenib—kidney cancer	2.24e-05	0.000528	CcSEcCtD
Fluorouracil—Pruritus—Sunitinib—kidney cancer	2.22e-05	0.000526	CcSEcCtD
Fluorouracil—Chest pain—Paclitaxel—kidney cancer	2.2e-05	0.000521	CcSEcCtD
Fluorouracil—Myalgia—Paclitaxel—kidney cancer	2.2e-05	0.000521	CcSEcCtD
Fluorouracil—Decreased appetite—Gemcitabine—kidney cancer	2.19e-05	0.000518	CcSEcCtD
Fluorouracil—Hypersensitivity—Dactinomycin—kidney cancer	2.19e-05	0.000518	CcSEcCtD
Fluorouracil—Arrhythmia—Capecitabine—kidney cancer	2.18e-05	0.000515	CcSEcCtD
Fluorouracil—Gastrointestinal disorder—Gemcitabine—kidney cancer	2.18e-05	0.000515	CcSEcCtD
Fluorouracil—Discomfort—Paclitaxel—kidney cancer	2.18e-05	0.000514	CcSEcCtD
Fluorouracil—Cardiac arrest—Doxorubicin—kidney cancer	2.16e-05	0.000511	CcSEcCtD
Fluorouracil—Dizziness—Sorafenib—kidney cancer	2.16e-05	0.000511	CcSEcCtD
Fluorouracil—Pain—Gemcitabine—kidney cancer	2.16e-05	0.00051	CcSEcCtD
Fluorouracil—Nausea—Erlotinib—kidney cancer	2.16e-05	0.00051	CcSEcCtD
Fluorouracil—Alopecia—Capecitabine—kidney cancer	2.16e-05	0.000509	CcSEcCtD
Fluorouracil—Diarrhoea—Sunitinib—kidney cancer	2.15e-05	0.000508	CcSEcCtD
Fluorouracil—TYMS—Vinorelbine—Vincristine—kidney cancer	2.15e-05	0.0184	CbGdCrCtD
Fluorouracil—TYMS—Vinorelbine—Vinblastine—kidney cancer	2.15e-05	0.0184	CbGdCrCtD
Fluorouracil—Ataxia—Doxorubicin—kidney cancer	2.14e-05	0.000505	CcSEcCtD
Fluorouracil—Confusional state—Paclitaxel—kidney cancer	2.13e-05	0.000503	CcSEcCtD
Fluorouracil—Erythema—Capecitabine—kidney cancer	2.12e-05	0.000502	CcSEcCtD
Fluorouracil—Oedema—Paclitaxel—kidney cancer	2.11e-05	0.000499	CcSEcCtD
Fluorouracil—Anaphylactic shock—Paclitaxel—kidney cancer	2.11e-05	0.000499	CcSEcCtD
Fluorouracil—Body temperature increased—Vincristine—kidney cancer	2.1e-05	0.000497	CcSEcCtD
Fluorouracil—Infection—Paclitaxel—kidney cancer	2.1e-05	0.000496	CcSEcCtD
Fluorouracil—Dry skin—Doxorubicin—kidney cancer	2.08e-05	0.000492	CcSEcCtD
Fluorouracil—Dizziness—Sunitinib—kidney cancer	2.08e-05	0.000491	CcSEcCtD
Fluorouracil—Feeling abnormal—Gemcitabine—kidney cancer	2.08e-05	0.000491	CcSEcCtD
Fluorouracil—Vomiting—Sorafenib—kidney cancer	2.08e-05	0.000491	CcSEcCtD
Fluorouracil—Nervous system disorder—Paclitaxel—kidney cancer	2.07e-05	0.000489	CcSEcCtD
Fluorouracil—Thrombocytopenia—Paclitaxel—kidney cancer	2.07e-05	0.000489	CcSEcCtD
Fluorouracil—Tachycardia—Paclitaxel—kidney cancer	2.06e-05	0.000487	CcSEcCtD
Fluorouracil—Rash—Sorafenib—kidney cancer	2.06e-05	0.000487	CcSEcCtD
Fluorouracil—Dermatitis—Sorafenib—kidney cancer	2.06e-05	0.000486	CcSEcCtD
Fluorouracil—Headache—Sorafenib—kidney cancer	2.05e-05	0.000484	CcSEcCtD
Fluorouracil—Diarrhoea—Dactinomycin—kidney cancer	2.04e-05	0.000481	CcSEcCtD
Fluorouracil—Nasopharyngitis—Doxorubicin—kidney cancer	2.03e-05	0.00048	CcSEcCtD
Fluorouracil—Anorexia—Paclitaxel—kidney cancer	2.01e-05	0.000476	CcSEcCtD
Fluorouracil—Muscular weakness—Doxorubicin—kidney cancer	2.01e-05	0.000474	CcSEcCtD
Fluorouracil—Vision blurred—Capecitabine—kidney cancer	2e-05	0.000473	CcSEcCtD
Fluorouracil—Vomiting—Sunitinib—kidney cancer	2e-05	0.000472	CcSEcCtD
Fluorouracil—Body temperature increased—Gemcitabine—kidney cancer	1.99e-05	0.000471	CcSEcCtD
Fluorouracil—Rash—Sunitinib—kidney cancer	1.98e-05	0.000468	CcSEcCtD
Fluorouracil—Dermatitis—Sunitinib—kidney cancer	1.98e-05	0.000468	CcSEcCtD
Fluorouracil—Hypotension—Paclitaxel—kidney cancer	1.97e-05	0.000466	CcSEcCtD
Fluorouracil—Headache—Sunitinib—kidney cancer	1.97e-05	0.000465	CcSEcCtD
Fluorouracil—Dysphagia—Doxorubicin—kidney cancer	1.97e-05	0.000464	CcSEcCtD
Fluorouracil—Anaemia—Capecitabine—kidney cancer	1.96e-05	0.000464	CcSEcCtD
Fluorouracil—Hypersensitivity—Vincristine—kidney cancer	1.96e-05	0.000463	CcSEcCtD
Fluorouracil—Eosinophilia—Doxorubicin—kidney cancer	1.95e-05	0.00046	CcSEcCtD
Fluorouracil—Nausea—Sorafenib—kidney cancer	1.94e-05	0.000459	CcSEcCtD
Fluorouracil—Musculoskeletal discomfort—Paclitaxel—kidney cancer	1.92e-05	0.000455	CcSEcCtD
Fluorouracil—Angina pectoris—Doxorubicin—kidney cancer	1.91e-05	0.000452	CcSEcCtD
Fluorouracil—Insomnia—Paclitaxel—kidney cancer	1.91e-05	0.000451	CcSEcCtD
Fluorouracil—Leukopenia—Capecitabine—kidney cancer	1.9e-05	0.000449	CcSEcCtD
Fluorouracil—Paraesthesia—Paclitaxel—kidney cancer	1.9e-05	0.000448	CcSEcCtD
Fluorouracil—Vomiting—Dactinomycin—kidney cancer	1.89e-05	0.000447	CcSEcCtD
Fluorouracil—Dyspnoea—Paclitaxel—kidney cancer	1.88e-05	0.000445	CcSEcCtD
Fluorouracil—Somnolence—Paclitaxel—kidney cancer	1.88e-05	0.000444	CcSEcCtD
Fluorouracil—Rash—Dactinomycin—kidney cancer	1.88e-05	0.000443	CcSEcCtD
Fluorouracil—Nausea—Sunitinib—kidney cancer	1.87e-05	0.000441	CcSEcCtD
Fluorouracil—Pancytopenia—Doxorubicin—kidney cancer	1.87e-05	0.000441	CcSEcCtD
Fluorouracil—Dyspepsia—Paclitaxel—kidney cancer	1.86e-05	0.000439	CcSEcCtD
Fluorouracil—TYMS—Vincristine—Vinblastine—kidney cancer	1.84e-05	0.0157	CbGdCrCtD
Fluorouracil—Decreased appetite—Paclitaxel—kidney cancer	1.84e-05	0.000434	CcSEcCtD
Fluorouracil—Upper respiratory tract infection—Doxorubicin—kidney cancer	1.83e-05	0.000431	CcSEcCtD
Fluorouracil—Gastrointestinal disorder—Paclitaxel—kidney cancer	1.82e-05	0.000431	CcSEcCtD
Fluorouracil—Diarrhoea—Vincristine—kidney cancer	1.82e-05	0.00043	CcSEcCtD
Fluorouracil—Myalgia—Capecitabine—kidney cancer	1.81e-05	0.000427	CcSEcCtD
Fluorouracil—Chest pain—Capecitabine—kidney cancer	1.81e-05	0.000427	CcSEcCtD
Fluorouracil—Pain—Paclitaxel—kidney cancer	1.81e-05	0.000427	CcSEcCtD
Fluorouracil—Photosensitivity reaction—Doxorubicin—kidney cancer	1.79e-05	0.000424	CcSEcCtD
Fluorouracil—Discomfort—Capecitabine—kidney cancer	1.79e-05	0.000422	CcSEcCtD
Fluorouracil—Pruritus—Gemcitabine—kidney cancer	1.79e-05	0.000422	CcSEcCtD
Fluorouracil—Nausea—Dactinomycin—kidney cancer	1.77e-05	0.000418	CcSEcCtD
Fluorouracil—Pneumonia—Doxorubicin—kidney cancer	1.76e-05	0.000416	CcSEcCtD
Fluorouracil—Dizziness—Vincristine—kidney cancer	1.76e-05	0.000416	CcSEcCtD
Fluorouracil—Infestation NOS—Doxorubicin—kidney cancer	1.75e-05	0.000414	CcSEcCtD
Fluorouracil—Infestation—Doxorubicin—kidney cancer	1.75e-05	0.000414	CcSEcCtD
Fluorouracil—Confusional state—Capecitabine—kidney cancer	1.75e-05	0.000413	CcSEcCtD
Fluorouracil—Feeling abnormal—Paclitaxel—kidney cancer	1.74e-05	0.000411	CcSEcCtD
Fluorouracil—Oedema—Capecitabine—kidney cancer	1.73e-05	0.00041	CcSEcCtD
Fluorouracil—Diarrhoea—Gemcitabine—kidney cancer	1.73e-05	0.000408	CcSEcCtD
Fluorouracil—Infection—Capecitabine—kidney cancer	1.72e-05	0.000407	CcSEcCtD
Fluorouracil—Neuropathy peripheral—Doxorubicin—kidney cancer	1.72e-05	0.000406	CcSEcCtD
Fluorouracil—Stomatitis—Doxorubicin—kidney cancer	1.71e-05	0.000403	CcSEcCtD
Fluorouracil—Urinary tract infection—Doxorubicin—kidney cancer	1.7e-05	0.000402	CcSEcCtD
Fluorouracil—Conjunctivitis—Doxorubicin—kidney cancer	1.7e-05	0.000402	CcSEcCtD
Fluorouracil—Nervous system disorder—Capecitabine—kidney cancer	1.7e-05	0.000402	CcSEcCtD
Fluorouracil—Thrombocytopenia—Capecitabine—kidney cancer	1.7e-05	0.000401	CcSEcCtD
Fluorouracil—Tachycardia—Capecitabine—kidney cancer	1.69e-05	0.0004	CcSEcCtD
Fluorouracil—Vomiting—Vincristine—kidney cancer	1.69e-05	0.0004	CcSEcCtD
Fluorouracil—Urticaria—Paclitaxel—kidney cancer	1.68e-05	0.000396	CcSEcCtD
Fluorouracil—Rash—Vincristine—kidney cancer	1.68e-05	0.000396	CcSEcCtD
Fluorouracil—Dermatitis—Vincristine—kidney cancer	1.68e-05	0.000396	CcSEcCtD
Fluorouracil—Body temperature increased—Paclitaxel—kidney cancer	1.67e-05	0.000395	CcSEcCtD
Fluorouracil—Headache—Vincristine—kidney cancer	1.67e-05	0.000394	CcSEcCtD
Fluorouracil—Epistaxis—Doxorubicin—kidney cancer	1.65e-05	0.00039	CcSEcCtD
Fluorouracil—Anorexia—Capecitabine—kidney cancer	1.65e-05	0.00039	CcSEcCtD
Fluorouracil—Sinusitis—Doxorubicin—kidney cancer	1.64e-05	0.000388	CcSEcCtD
Fluorouracil—Agranulocytosis—Doxorubicin—kidney cancer	1.64e-05	0.000386	CcSEcCtD
Fluorouracil—Hypotension—Capecitabine—kidney cancer	1.62e-05	0.000383	CcSEcCtD
Fluorouracil—Vomiting—Gemcitabine—kidney cancer	1.6e-05	0.000379	CcSEcCtD
Fluorouracil—Rash—Gemcitabine—kidney cancer	1.59e-05	0.000376	CcSEcCtD
Fluorouracil—Dermatitis—Gemcitabine—kidney cancer	1.59e-05	0.000375	CcSEcCtD
Fluorouracil—Haemoglobin—Doxorubicin—kidney cancer	1.58e-05	0.000373	CcSEcCtD
Fluorouracil—Headache—Gemcitabine—kidney cancer	1.58e-05	0.000373	CcSEcCtD
Fluorouracil—Nausea—Vincristine—kidney cancer	1.58e-05	0.000373	CcSEcCtD
Fluorouracil—Musculoskeletal discomfort—Capecitabine—kidney cancer	1.58e-05	0.000373	CcSEcCtD
Fluorouracil—Rhinitis—Doxorubicin—kidney cancer	1.58e-05	0.000373	CcSEcCtD
Fluorouracil—Haemorrhage—Doxorubicin—kidney cancer	1.57e-05	0.000372	CcSEcCtD
Fluorouracil—Insomnia—Capecitabine—kidney cancer	1.57e-05	0.00037	CcSEcCtD
Fluorouracil—Hypoaesthesia—Doxorubicin—kidney cancer	1.57e-05	0.00037	CcSEcCtD
Fluorouracil—Pharyngitis—Doxorubicin—kidney cancer	1.56e-05	0.000369	CcSEcCtD
Fluorouracil—Paraesthesia—Capecitabine—kidney cancer	1.56e-05	0.000368	CcSEcCtD
Fluorouracil—Hypersensitivity—Paclitaxel—kidney cancer	1.56e-05	0.000368	CcSEcCtD
Fluorouracil—Dyspnoea—Capecitabine—kidney cancer	1.55e-05	0.000365	CcSEcCtD
Fluorouracil—Dyspepsia—Capecitabine—kidney cancer	1.53e-05	0.000361	CcSEcCtD
Fluorouracil—Decreased appetite—Capecitabine—kidney cancer	1.51e-05	0.000356	CcSEcCtD
Fluorouracil—Nausea—Gemcitabine—kidney cancer	1.5e-05	0.000354	CcSEcCtD
Fluorouracil—Gastrointestinal disorder—Capecitabine—kidney cancer	1.5e-05	0.000354	CcSEcCtD
Fluorouracil—Pruritus—Paclitaxel—kidney cancer	1.49e-05	0.000353	CcSEcCtD
Fluorouracil—Pain—Capecitabine—kidney cancer	1.48e-05	0.00035	CcSEcCtD
Fluorouracil—TYMS—Vinblastine—Vincristine—kidney cancer	1.48e-05	0.0126	CbGdCrCtD
Fluorouracil—Diarrhoea—Paclitaxel—kidney cancer	1.45e-05	0.000341	CcSEcCtD
Fluorouracil—Feeling abnormal—Capecitabine—kidney cancer	1.43e-05	0.000338	CcSEcCtD
Fluorouracil—Arrhythmia—Doxorubicin—kidney cancer	1.41e-05	0.000332	CcSEcCtD
Fluorouracil—Dizziness—Paclitaxel—kidney cancer	1.4e-05	0.00033	CcSEcCtD
Fluorouracil—Alopecia—Doxorubicin—kidney cancer	1.39e-05	0.000328	CcSEcCtD
Fluorouracil—Urticaria—Capecitabine—kidney cancer	1.38e-05	0.000325	CcSEcCtD
Fluorouracil—Body temperature increased—Capecitabine—kidney cancer	1.37e-05	0.000324	CcSEcCtD
Fluorouracil—Erythema—Doxorubicin—kidney cancer	1.37e-05	0.000323	CcSEcCtD
Fluorouracil—Vomiting—Paclitaxel—kidney cancer	1.34e-05	0.000317	CcSEcCtD
Fluorouracil—Rash—Paclitaxel—kidney cancer	1.33e-05	0.000315	CcSEcCtD
Fluorouracil—Dermatitis—Paclitaxel—kidney cancer	1.33e-05	0.000314	CcSEcCtD
Fluorouracil—Headache—Paclitaxel—kidney cancer	1.32e-05	0.000313	CcSEcCtD
Fluorouracil—Vision blurred—Doxorubicin—kidney cancer	1.29e-05	0.000305	CcSEcCtD
Fluorouracil—Hypersensitivity—Capecitabine—kidney cancer	1.28e-05	0.000302	CcSEcCtD
Fluorouracil—Anaemia—Doxorubicin—kidney cancer	1.27e-05	0.000299	CcSEcCtD
Fluorouracil—Nausea—Paclitaxel—kidney cancer	1.25e-05	0.000296	CcSEcCtD
Fluorouracil—Pruritus—Capecitabine—kidney cancer	1.23e-05	0.00029	CcSEcCtD
Fluorouracil—Leukopenia—Doxorubicin—kidney cancer	1.23e-05	0.00029	CcSEcCtD
Fluorouracil—Convulsion—Doxorubicin—kidney cancer	1.19e-05	0.00028	CcSEcCtD
Fluorouracil—Diarrhoea—Capecitabine—kidney cancer	1.19e-05	0.00028	CcSEcCtD
Fluorouracil—Chest pain—Doxorubicin—kidney cancer	1.17e-05	0.000275	CcSEcCtD
Fluorouracil—Myalgia—Doxorubicin—kidney cancer	1.17e-05	0.000275	CcSEcCtD
Fluorouracil—Discomfort—Doxorubicin—kidney cancer	1.15e-05	0.000272	CcSEcCtD
Fluorouracil—Dizziness—Capecitabine—kidney cancer	1.15e-05	0.000271	CcSEcCtD
Fluorouracil—Confusional state—Doxorubicin—kidney cancer	1.13e-05	0.000266	CcSEcCtD
Fluorouracil—Oedema—Doxorubicin—kidney cancer	1.12e-05	0.000264	CcSEcCtD
Fluorouracil—Anaphylactic shock—Doxorubicin—kidney cancer	1.12e-05	0.000264	CcSEcCtD
Fluorouracil—Infection—Doxorubicin—kidney cancer	1.11e-05	0.000262	CcSEcCtD
Fluorouracil—Vomiting—Capecitabine—kidney cancer	1.1e-05	0.00026	CcSEcCtD
Fluorouracil—Nervous system disorder—Doxorubicin—kidney cancer	1.1e-05	0.000259	CcSEcCtD
Fluorouracil—Thrombocytopenia—Doxorubicin—kidney cancer	1.09e-05	0.000258	CcSEcCtD
Fluorouracil—Rash—Capecitabine—kidney cancer	1.09e-05	0.000258	CcSEcCtD
Fluorouracil—Dermatitis—Capecitabine—kidney cancer	1.09e-05	0.000258	CcSEcCtD
Fluorouracil—Tachycardia—Doxorubicin—kidney cancer	1.09e-05	0.000258	CcSEcCtD
Fluorouracil—Headache—Capecitabine—kidney cancer	1.09e-05	0.000257	CcSEcCtD
Fluorouracil—Anorexia—Doxorubicin—kidney cancer	1.07e-05	0.000252	CcSEcCtD
Fluorouracil—Hypotension—Doxorubicin—kidney cancer	1.04e-05	0.000247	CcSEcCtD
Fluorouracil—Nausea—Capecitabine—kidney cancer	1.03e-05	0.000243	CcSEcCtD
Fluorouracil—Musculoskeletal discomfort—Doxorubicin—kidney cancer	1.02e-05	0.000241	CcSEcCtD
Fluorouracil—Insomnia—Doxorubicin—kidney cancer	1.01e-05	0.000239	CcSEcCtD
Fluorouracil—Paraesthesia—Doxorubicin—kidney cancer	1e-05	0.000237	CcSEcCtD
Fluorouracil—Dyspnoea—Doxorubicin—kidney cancer	9.96e-06	0.000235	CcSEcCtD
Fluorouracil—Somnolence—Doxorubicin—kidney cancer	9.93e-06	0.000235	CcSEcCtD
Fluorouracil—Dyspepsia—Doxorubicin—kidney cancer	9.84e-06	0.000232	CcSEcCtD
Fluorouracil—Decreased appetite—Doxorubicin—kidney cancer	9.71e-06	0.000229	CcSEcCtD
Fluorouracil—Gastrointestinal disorder—Doxorubicin—kidney cancer	9.65e-06	0.000228	CcSEcCtD
Fluorouracil—Pain—Doxorubicin—kidney cancer	9.56e-06	0.000226	CcSEcCtD
Fluorouracil—Feeling abnormal—Doxorubicin—kidney cancer	9.21e-06	0.000218	CcSEcCtD
Fluorouracil—Urticaria—Doxorubicin—kidney cancer	8.88e-06	0.00021	CcSEcCtD
Fluorouracil—Body temperature increased—Doxorubicin—kidney cancer	8.83e-06	0.000209	CcSEcCtD
Fluorouracil—TYMS—Azacitidine—Gemcitabine—kidney cancer	8.66e-06	0.00741	CbGdCrCtD
Fluorouracil—Hypersensitivity—Doxorubicin—kidney cancer	8.23e-06	0.000195	CcSEcCtD
Fluorouracil—Pruritus—Doxorubicin—kidney cancer	7.91e-06	0.000187	CcSEcCtD
Fluorouracil—Diarrhoea—Doxorubicin—kidney cancer	7.65e-06	0.000181	CcSEcCtD
Fluorouracil—Dizziness—Doxorubicin—kidney cancer	7.39e-06	0.000175	CcSEcCtD
Fluorouracil—Vomiting—Doxorubicin—kidney cancer	7.11e-06	0.000168	CcSEcCtD
Fluorouracil—Rash—Doxorubicin—kidney cancer	7.05e-06	0.000166	CcSEcCtD
Fluorouracil—Dermatitis—Doxorubicin—kidney cancer	7.04e-06	0.000166	CcSEcCtD
Fluorouracil—Headache—Doxorubicin—kidney cancer	7e-06	0.000165	CcSEcCtD
Fluorouracil—Nausea—Doxorubicin—kidney cancer	6.64e-06	0.000157	CcSEcCtD
Fluorouracil—CYP2C8—Metabolism—ST3GAL2—kidney cancer	2.66e-06	0.000102	CbGpPWpGaD
Fluorouracil—ALB—Metabolism—ST3GAL2—kidney cancer	2.64e-06	0.000101	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism of lipids and lipoproteins—SCARB1—kidney cancer	2.64e-06	0.000101	CbGpPWpGaD
Fluorouracil—TYMP—Metabolism—PTEN—kidney cancer	2.64e-06	0.000101	CbGpPWpGaD
Fluorouracil—CYP2A6—Metabolism—CRABP1—kidney cancer	2.63e-06	0.000101	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—CCBL1—kidney cancer	2.63e-06	0.000101	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism of lipids and lipoproteins—PTGS1—kidney cancer	2.61e-06	0.0001	CbGpPWpGaD
Fluorouracil—PPAT—Metabolism—PIK3CA—kidney cancer	2.61e-06	0.0001	CbGpPWpGaD
Fluorouracil—DPYD—Metabolism—PIK3CA—kidney cancer	2.61e-06	0.0001	CbGpPWpGaD
Fluorouracil—TYMS—Cell Cycle—MYC—kidney cancer	2.61e-06	0.0001	CbGpPWpGaD
Fluorouracil—TYMS—Metabolism—CYP1A1—kidney cancer	2.6e-06	0.0001	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism—ALDH1A1—kidney cancer	2.6e-06	9.98e-05	CbGpPWpGaD
Fluorouracil—ALB—Metabolism—ALDH1A1—kidney cancer	2.58e-06	9.92e-05	CbGpPWpGaD
Fluorouracil—ABCC5—Disease—BRAF—kidney cancer	2.57e-06	9.87e-05	CbGpPWpGaD
Fluorouracil—TYMS—Cell Cycle—MAPK1—kidney cancer	2.55e-06	9.81e-05	CbGpPWpGaD
Fluorouracil—ALB—Hemostasis—IGF2—kidney cancer	2.52e-06	9.7e-05	CbGpPWpGaD
Fluorouracil—ABCC3—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	2.51e-06	9.63e-05	CbGpPWpGaD
Fluorouracil—MTHFR—Metabolism—POMC—kidney cancer	2.5e-06	9.61e-05	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism—SLC5A3—kidney cancer	2.49e-06	9.57e-05	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism—PGK1—kidney cancer	2.49e-06	9.57e-05	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—APRT—kidney cancer	2.48e-06	9.55e-05	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—FH—kidney cancer	2.48e-06	9.55e-05	CbGpPWpGaD
Fluorouracil—ALB—Metabolism—PGK1—kidney cancer	2.47e-06	9.51e-05	CbGpPWpGaD
Fluorouracil—ALB—Metabolism—SLC5A3—kidney cancer	2.47e-06	9.51e-05	CbGpPWpGaD
Fluorouracil—ABCC3—Metabolism—GSTP1—kidney cancer	2.47e-06	9.5e-05	CbGpPWpGaD
Fluorouracil—MTHFR—Disease—RAF1—kidney cancer	2.46e-06	9.46e-05	CbGpPWpGaD
Fluorouracil—ABCG2—Metabolism—ACHE—kidney cancer	2.46e-06	9.45e-05	CbGpPWpGaD
Fluorouracil—ABCG2—Metabolism—GSTT1—kidney cancer	2.46e-06	9.45e-05	CbGpPWpGaD
Fluorouracil—CYP2A6—Metabolism—ITPR2—kidney cancer	2.45e-06	9.41e-05	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism—LDHB—kidney cancer	2.44e-06	9.38e-05	CbGpPWpGaD
Fluorouracil—MTHFR—Disease—ERBB2—kidney cancer	2.44e-06	9.36e-05	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism of lipids and lipoproteins—BCHE—kidney cancer	2.43e-06	9.33e-05	CbGpPWpGaD
Fluorouracil—ALB—Metabolism—LDHB—kidney cancer	2.43e-06	9.33e-05	CbGpPWpGaD
Fluorouracil—ALB—Platelet activation, signaling and aggregation—IL2—kidney cancer	2.42e-06	9.28e-05	CbGpPWpGaD
Fluorouracil—MTHFR—Disease—MTOR—kidney cancer	2.4e-06	9.24e-05	CbGpPWpGaD
Fluorouracil—MTHFR—Disease—CD4—kidney cancer	2.4e-06	9.22e-05	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism of lipids and lipoproteins—ACHE—kidney cancer	2.38e-06	9.16e-05	CbGpPWpGaD
Fluorouracil—MTHFR—Disease—PTGS2—kidney cancer	2.38e-06	9.15e-05	CbGpPWpGaD
Fluorouracil—ABCC3—Metabolism—ABCB1—kidney cancer	2.34e-06	8.99e-05	CbGpPWpGaD
Fluorouracil—ABCC4—Hemostasis—VEGFA—kidney cancer	2.34e-06	8.99e-05	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—GPC3—kidney cancer	2.34e-06	8.98e-05	CbGpPWpGaD
Fluorouracil—ABCG2—Metabolism—SCARB1—kidney cancer	2.33e-06	8.94e-05	CbGpPWpGaD
Fluorouracil—ABCG2—Metabolism—PTGS1—kidney cancer	2.3e-06	8.85e-05	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—GLIPR1—kidney cancer	2.28e-06	8.78e-05	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—PPAT—kidney cancer	2.28e-06	8.78e-05	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—CA2—kidney cancer	2.27e-06	8.73e-05	CbGpPWpGaD
Fluorouracil—ABCC3—Metabolism—GSTM1—kidney cancer	2.27e-06	8.73e-05	CbGpPWpGaD
Fluorouracil—ABCG2—Metabolism—PSMD7—kidney cancer	2.26e-06	8.68e-05	CbGpPWpGaD
Fluorouracil—MTHFR—Disease—CDKN1B—kidney cancer	2.26e-06	8.67e-05	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism of lipids and lipoproteins—SCARB1—kidney cancer	2.26e-06	8.67e-05	CbGpPWpGaD
Fluorouracil—CYP2A6—Metabolism—ACHE—kidney cancer	2.23e-06	8.58e-05	CbGpPWpGaD
Fluorouracil—CYP2A6—Metabolism—GSTT1—kidney cancer	2.23e-06	8.58e-05	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism of lipids and lipoproteins—PTGS1—kidney cancer	2.23e-06	8.58e-05	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—ALAD—kidney cancer	2.21e-06	8.51e-05	CbGpPWpGaD
Fluorouracil—ABCC4—Hemostasis—MAPK3—kidney cancer	2.21e-06	8.5e-05	CbGpPWpGaD
Fluorouracil—ABCC5—Metabolism—POMC—kidney cancer	2.18e-06	8.37e-05	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—ST3GAL2—kidney cancer	2.16e-06	8.31e-05	CbGpPWpGaD
Fluorouracil—ABCC3—Metabolism—CYP1A1—kidney cancer	2.15e-06	8.27e-05	CbGpPWpGaD
Fluorouracil—ABCC5—Disease—RAF1—kidney cancer	2.14e-06	8.24e-05	CbGpPWpGaD
Fluorouracil—TYMS—Cell Cycle—TP53—kidney cancer	2.14e-06	8.23e-05	CbGpPWpGaD
Fluorouracil—ABCG2—Metabolism—BCHE—kidney cancer	2.14e-06	8.23e-05	CbGpPWpGaD
Fluorouracil—MTHFR—Disease—CTNNB1—kidney cancer	2.13e-06	8.19e-05	CbGpPWpGaD
Fluorouracil—ALB—Transmembrane transport of small molecules—ABCB1—kidney cancer	2.12e-06	8.17e-05	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—FH—kidney cancer	2.12e-06	8.16e-05	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—APRT—kidney cancer	2.12e-06	8.16e-05	CbGpPWpGaD
Fluorouracil—ABCC5—Disease—ERBB2—kidney cancer	2.12e-06	8.15e-05	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism—CA9—kidney cancer	2.12e-06	8.13e-05	CbGpPWpGaD
Fluorouracil—ABCG2—Metabolism—SLC5A5—kidney cancer	2.12e-06	8.13e-05	CbGpPWpGaD
Fluorouracil—CYP2A6—Metabolism—SCARB1—kidney cancer	2.11e-06	8.12e-05	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—ALDH1A1—kidney cancer	2.11e-06	8.12e-05	CbGpPWpGaD
Fluorouracil—ABCC4—Hemostasis—MAPK1—kidney cancer	2.1e-06	8.09e-05	CbGpPWpGaD
Fluorouracil—ALB—Metabolism—CA9—kidney cancer	2.1e-06	8.09e-05	CbGpPWpGaD
Fluorouracil—ABCC5—Disease—MTOR—kidney cancer	2.09e-06	8.04e-05	CbGpPWpGaD
Fluorouracil—CYP2A6—Metabolism—PTGS1—kidney cancer	2.09e-06	8.04e-05	CbGpPWpGaD
Fluorouracil—ABCC5—Disease—CD4—kidney cancer	2.09e-06	8.03e-05	CbGpPWpGaD
Fluorouracil—MTHFR—Disease—PTEN—kidney cancer	2.08e-06	7.98e-05	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism of lipids and lipoproteins—BCHE—kidney cancer	2.08e-06	7.98e-05	CbGpPWpGaD
Fluorouracil—ABCC5—Disease—PTGS2—kidney cancer	2.07e-06	7.97e-05	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism of lipids and lipoproteins—CYP1A1—kidney cancer	2.07e-06	7.95e-05	CbGpPWpGaD
Fluorouracil—ALB—Metabolism of lipids and lipoproteins—CYP1A1—kidney cancer	2.06e-06	7.9e-05	CbGpPWpGaD
Fluorouracil—ALB—Platelet activation, signaling and aggregation—VEGFA—kidney cancer	2.05e-06	7.89e-05	CbGpPWpGaD
Fluorouracil—CYP2A6—Metabolism—PSMD7—kidney cancer	2.05e-06	7.89e-05	CbGpPWpGaD
Fluorouracil—ABCG2—Metabolism—SLC2A1—kidney cancer	2.04e-06	7.85e-05	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—SLC5A3—kidney cancer	2.03e-06	7.78e-05	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—PGK1—kidney cancer	2.03e-06	7.78e-05	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—GPC3—kidney cancer	2e-06	7.67e-05	CbGpPWpGaD
Fluorouracil—MTHFR—Metabolism—PTGS2—kidney cancer	1.99e-06	7.67e-05	CbGpPWpGaD
Fluorouracil—ABCC4—Hemostasis—KRAS—kidney cancer	1.99e-06	7.64e-05	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—LDHB—kidney cancer	1.99e-06	7.63e-05	CbGpPWpGaD
Fluorouracil—ABCC5—Disease—CDKN1B—kidney cancer	1.96e-06	7.55e-05	CbGpPWpGaD
Fluorouracil—ABCG2—Transmembrane transport of small molecules—RAF1—kidney cancer	1.95e-06	7.49e-05	CbGpPWpGaD
Fluorouracil—CYP2A6—Metabolism—BCHE—kidney cancer	1.95e-06	7.48e-05	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—CA2—kidney cancer	1.94e-06	7.46e-05	CbGpPWpGaD
Fluorouracil—ALB—Platelet activation, signaling and aggregation—MAPK3—kidney cancer	1.94e-06	7.46e-05	CbGpPWpGaD
Fluorouracil—TYMS—Metabolism—POMC—kidney cancer	1.94e-06	7.45e-05	CbGpPWpGaD
Fluorouracil—CYP2A6—Metabolism—SLC5A5—kidney cancer	1.92e-06	7.39e-05	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—ALAD—kidney cancer	1.89e-06	7.27e-05	CbGpPWpGaD
Fluorouracil—TYMP—Metabolism—PIK3CA—kidney cancer	1.86e-06	7.15e-05	CbGpPWpGaD
Fluorouracil—CYP2A6—Metabolism—SLC2A1—kidney cancer	1.86e-06	7.13e-05	CbGpPWpGaD
Fluorouracil—ABCC5—Disease—CTNNB1—kidney cancer	1.86e-06	7.13e-05	CbGpPWpGaD
Fluorouracil—ALB—Platelet activation, signaling and aggregation—MAPK1—kidney cancer	1.85e-06	7.1e-05	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—ST3GAL2—kidney cancer	1.85e-06	7.1e-05	CbGpPWpGaD
Fluorouracil—ABCC4—Hemostasis—PIK3CA—kidney cancer	1.83e-06	7.02e-05	CbGpPWpGaD
Fluorouracil—ABCC5—Disease—PTEN—kidney cancer	1.81e-06	6.95e-05	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—ALDH1A1—kidney cancer	1.81e-06	6.94e-05	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism—CRABP1—kidney cancer	1.8e-06	6.92e-05	CbGpPWpGaD
Fluorouracil—ALB—Metabolism—CRABP1—kidney cancer	1.79e-06	6.88e-05	CbGpPWpGaD
Fluorouracil—MTHFR—Disease—MAPK3—kidney cancer	1.77e-06	6.82e-05	CbGpPWpGaD
Fluorouracil—ABCC3—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	1.77e-06	6.8e-05	CbGpPWpGaD
Fluorouracil—ABCC4—Hemostasis—TP53—kidney cancer	1.77e-06	6.79e-05	CbGpPWpGaD
Fluorouracil—MTHFR—Metabolism—PTEN—kidney cancer	1.74e-06	6.69e-05	CbGpPWpGaD
Fluorouracil—ABCC5—Metabolism—PTGS2—kidney cancer	1.74e-06	6.67e-05	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—PGK1—kidney cancer	1.73e-06	6.65e-05	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—SLC5A3—kidney cancer	1.73e-06	6.65e-05	CbGpPWpGaD
Fluorouracil—MTHFR—Disease—MYC—kidney cancer	1.73e-06	6.63e-05	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—CA9—kidney cancer	1.72e-06	6.62e-05	CbGpPWpGaD
Fluorouracil—ABCG2—Metabolism—GSTP1—kidney cancer	1.7e-06	6.55e-05	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—LDHB—kidney cancer	1.7e-06	6.52e-05	CbGpPWpGaD
Fluorouracil—MTHFR—Disease—MAPK1—kidney cancer	1.69e-06	6.49e-05	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—kidney cancer	1.68e-06	6.47e-05	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism—ITPR2—kidney cancer	1.67e-06	6.43e-05	CbGpPWpGaD
Fluorouracil—ALB—Metabolism—ITPR2—kidney cancer	1.66e-06	6.39e-05	CbGpPWpGaD
Fluorouracil—ABCG2—Metabolism—ABCB1—kidney cancer	1.61e-06	6.2e-05	CbGpPWpGaD
Fluorouracil—ABCC3—Metabolism—POMC—kidney cancer	1.61e-06	6.17e-05	CbGpPWpGaD
Fluorouracil—ALB—Platelet activation, signaling and aggregation—PIK3CA—kidney cancer	1.6e-06	6.16e-05	CbGpPWpGaD
Fluorouracil—MTHFR—Disease—KRAS—kidney cancer	1.6e-06	6.13e-05	CbGpPWpGaD
Fluorouracil—ABCG2—Metabolism—GSTM1—kidney cancer	1.57e-06	6.02e-05	CbGpPWpGaD
Fluorouracil—CYP2A6—Metabolism—GSTP1—kidney cancer	1.55e-06	5.95e-05	CbGpPWpGaD
Fluorouracil—TYMS—Metabolism—PTGS2—kidney cancer	1.55e-06	5.94e-05	CbGpPWpGaD
Fluorouracil—ABCC5—Disease—MAPK3—kidney cancer	1.55e-06	5.94e-05	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism of lipids and lipoproteins—POMC—kidney cancer	1.54e-06	5.93e-05	CbGpPWpGaD
Fluorouracil—ALB—Metabolism of lipids and lipoproteins—POMC—kidney cancer	1.53e-06	5.89e-05	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism—ACHE—kidney cancer	1.53e-06	5.86e-05	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism—GSTT1—kidney cancer	1.53e-06	5.86e-05	CbGpPWpGaD
Fluorouracil—ALB—Metabolism—ACHE—kidney cancer	1.52e-06	5.83e-05	CbGpPWpGaD
Fluorouracil—ALB—Metabolism—GSTT1—kidney cancer	1.52e-06	5.83e-05	CbGpPWpGaD
Fluorouracil—ABCC5—Metabolism—PTEN—kidney cancer	1.51e-06	5.82e-05	CbGpPWpGaD
Fluorouracil—ABCC5—Disease—MYC—kidney cancer	1.5e-06	5.78e-05	CbGpPWpGaD
Fluorouracil—ABCG2—Metabolism—CYP1A1—kidney cancer	1.48e-06	5.7e-05	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—CA9—kidney cancer	1.47e-06	5.66e-05	CbGpPWpGaD
Fluorouracil—ABCC5—Disease—MAPK1—kidney cancer	1.47e-06	5.65e-05	CbGpPWpGaD
Fluorouracil—MTHFR—Disease—PIK3CA—kidney cancer	1.47e-06	5.63e-05	CbGpPWpGaD
Fluorouracil—CYP2A6—Metabolism—ABCB1—kidney cancer	1.47e-06	5.63e-05	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—CRABP1—kidney cancer	1.46e-06	5.63e-05	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism—SCARB1—kidney cancer	1.44e-06	5.55e-05	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism of lipids and lipoproteins—CYP1A1—kidney cancer	1.44e-06	5.53e-05	CbGpPWpGaD
Fluorouracil—ALB—Metabolism—SCARB1—kidney cancer	1.44e-06	5.52e-05	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism—PTGS1—kidney cancer	1.43e-06	5.49e-05	CbGpPWpGaD
Fluorouracil—CYP2A6—Metabolism—GSTM1—kidney cancer	1.42e-06	5.47e-05	CbGpPWpGaD
Fluorouracil—ALB—Metabolism—PTGS1—kidney cancer	1.42e-06	5.46e-05	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism—PSMD7—kidney cancer	1.4e-06	5.39e-05	CbGpPWpGaD
Fluorouracil—ALB—Metabolism—PSMD7—kidney cancer	1.39e-06	5.36e-05	CbGpPWpGaD
Fluorouracil—ALB—Hemostasis—RAF1—kidney cancer	1.39e-06	5.34e-05	CbGpPWpGaD
Fluorouracil—ABCC5—Disease—KRAS—kidney cancer	1.39e-06	5.34e-05	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—ITPR2—kidney cancer	1.36e-06	5.23e-05	CbGpPWpGaD
Fluorouracil—TYMS—Metabolism—PTEN—kidney cancer	1.35e-06	5.18e-05	CbGpPWpGaD
Fluorouracil—CYP2A6—Metabolism—CYP1A1—kidney cancer	1.35e-06	5.18e-05	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism—BCHE—kidney cancer	1.33e-06	5.11e-05	CbGpPWpGaD
Fluorouracil—ALB—Metabolism—BCHE—kidney cancer	1.32e-06	5.08e-05	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism—SLC5A5—kidney cancer	1.31e-06	5.04e-05	CbGpPWpGaD
Fluorouracil—ALB—Metabolism—SLC5A5—kidney cancer	1.31e-06	5.02e-05	CbGpPWpGaD
Fluorouracil—ABCC3—Metabolism—PTGS2—kidney cancer	1.28e-06	4.92e-05	CbGpPWpGaD
Fluorouracil—ABCC5—Disease—PIK3CA—kidney cancer	1.28e-06	4.9e-05	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism—SLC2A1—kidney cancer	1.27e-06	4.87e-05	CbGpPWpGaD
Fluorouracil—ALB—Metabolism—SLC2A1—kidney cancer	1.26e-06	4.84e-05	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism of lipids and lipoproteins—POMC—kidney cancer	1.26e-06	4.82e-05	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—CRABP1—kidney cancer	1.25e-06	4.81e-05	CbGpPWpGaD
Fluorouracil—ALB—Hemostasis—IL2—kidney cancer	1.25e-06	4.79e-05	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—GSTT1—kidney cancer	1.24e-06	4.77e-05	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—ACHE—kidney cancer	1.24e-06	4.77e-05	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	1.23e-06	4.73e-05	CbGpPWpGaD
Fluorouracil—MTHFR—Metabolism—PIK3CA—kidney cancer	1.23e-06	4.72e-05	CbGpPWpGaD
Fluorouracil—ALB—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	1.22e-06	4.7e-05	CbGpPWpGaD
Fluorouracil—ALB—Transmembrane transport of small molecules—RAF1—kidney cancer	1.2e-06	4.62e-05	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—SCARB1—kidney cancer	1.18e-06	4.52e-05	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—ITPR2—kidney cancer	1.16e-06	4.47e-05	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—PTGS1—kidney cancer	1.16e-06	4.47e-05	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—PSMD7—kidney cancer	1.14e-06	4.38e-05	CbGpPWpGaD
Fluorouracil—ABCC3—Metabolism—PTEN—kidney cancer	1.12e-06	4.29e-05	CbGpPWpGaD
Fluorouracil—ABCG2—Metabolism—POMC—kidney cancer	1.11e-06	4.25e-05	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—BCHE—kidney cancer	1.08e-06	4.16e-05	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	1.07e-06	4.12e-05	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism of lipids and lipoproteins—POMC—kidney cancer	1.07e-06	4.12e-05	CbGpPWpGaD
Fluorouracil—ABCC5—Metabolism—PIK3CA—kidney cancer	1.07e-06	4.11e-05	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—SLC5A5—kidney cancer	1.07e-06	4.11e-05	CbGpPWpGaD
Fluorouracil—ALB—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	1.07e-06	4.1e-05	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—ACHE—kidney cancer	1.06e-06	4.08e-05	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—GSTT1—kidney cancer	1.06e-06	4.08e-05	CbGpPWpGaD
Fluorouracil—ALB—Hemostasis—VEGFA—kidney cancer	1.06e-06	4.07e-05	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism—GSTP1—kidney cancer	1.06e-06	4.06e-05	CbGpPWpGaD
Fluorouracil—ALB—Metabolism—GSTP1—kidney cancer	1.05e-06	4.04e-05	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—SLC2A1—kidney cancer	1.03e-06	3.97e-05	CbGpPWpGaD
Fluorouracil—CYP2A6—Metabolism—POMC—kidney cancer	1.01e-06	3.86e-05	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—SCARB1—kidney cancer	1e-06	3.86e-05	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	1e-06	3.85e-05	CbGpPWpGaD
Fluorouracil—ALB—Hemostasis—MAPK3—kidney cancer	1e-06	3.85e-05	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism—ABCB1—kidney cancer	1e-06	3.85e-05	CbGpPWpGaD
Fluorouracil—ALB—Metabolism—ABCB1—kidney cancer	9.95e-07	3.82e-05	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—PTGS1—kidney cancer	9.94e-07	3.82e-05	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—PSMD7—kidney cancer	9.75e-07	3.75e-05	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism—GSTM1—kidney cancer	9.72e-07	3.73e-05	CbGpPWpGaD
Fluorouracil—ALB—Metabolism—GSTM1—kidney cancer	9.66e-07	3.71e-05	CbGpPWpGaD
Fluorouracil—ALB—Hemostasis—MAPK1—kidney cancer	9.53e-07	3.66e-05	CbGpPWpGaD
Fluorouracil—TYMS—Metabolism—PIK3CA—kidney cancer	9.52e-07	3.66e-05	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—BCHE—kidney cancer	9.24e-07	3.55e-05	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism—CYP1A1—kidney cancer	9.21e-07	3.54e-05	CbGpPWpGaD
Fluorouracil—ALB—Metabolism—CYP1A1—kidney cancer	9.16e-07	3.52e-05	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—SLC5A5—kidney cancer	9.13e-07	3.51e-05	CbGpPWpGaD
Fluorouracil—ALB—Hemostasis—KRAS—kidney cancer	9e-07	3.46e-05	CbGpPWpGaD
Fluorouracil—ABCG2—Metabolism—PTGS2—kidney cancer	8.83e-07	3.39e-05	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—SLC2A1—kidney cancer	8.82e-07	3.39e-05	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	8.73e-07	3.36e-05	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—GSTP1—kidney cancer	8.61e-07	3.31e-05	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	8.55e-07	3.29e-05	CbGpPWpGaD
Fluorouracil—ALB—Hemostasis—PIK3CA—kidney cancer	8.27e-07	3.18e-05	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—ABCB1—kidney cancer	8.15e-07	3.13e-05	CbGpPWpGaD
Fluorouracil—CYP2A6—Metabolism—PTGS2—kidney cancer	8.02e-07	3.08e-05	CbGpPWpGaD
Fluorouracil—ALB—Hemostasis—TP53—kidney cancer	8e-07	3.07e-05	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—GSTM1—kidney cancer	7.91e-07	3.04e-05	CbGpPWpGaD
Fluorouracil—ABCC3—Metabolism—PIK3CA—kidney cancer	7.88e-07	3.03e-05	CbGpPWpGaD
Fluorouracil—ABCG2—Metabolism—PTEN—kidney cancer	7.7e-07	2.96e-05	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	7.57e-07	2.91e-05	CbGpPWpGaD
Fluorouracil—ALB—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	7.52e-07	2.89e-05	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—CYP1A1—kidney cancer	7.5e-07	2.88e-05	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	7.46e-07	2.87e-05	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—GSTP1—kidney cancer	7.35e-07	2.83e-05	CbGpPWpGaD
Fluorouracil—CYP2A6—Metabolism—PTEN—kidney cancer	6.99e-07	2.69e-05	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—ABCB1—kidney cancer	6.96e-07	2.68e-05	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism—POMC—kidney cancer	6.87e-07	2.64e-05	CbGpPWpGaD
Fluorouracil—ALB—Metabolism—POMC—kidney cancer	6.83e-07	2.62e-05	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—GSTM1—kidney cancer	6.76e-07	2.6e-05	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—CYP1A1—kidney cancer	6.41e-07	2.46e-05	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	6.16e-07	2.37e-05	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—POMC—kidney cancer	5.59e-07	2.15e-05	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism—PTGS2—kidney cancer	5.48e-07	2.11e-05	CbGpPWpGaD
Fluorouracil—ALB—Metabolism—PTGS2—kidney cancer	5.45e-07	2.09e-05	CbGpPWpGaD
Fluorouracil—ABCG2—Metabolism—PIK3CA—kidney cancer	5.43e-07	2.09e-05	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	5.26e-07	2.02e-05	CbGpPWpGaD
Fluorouracil—CYP2A6—Metabolism—PIK3CA—kidney cancer	4.93e-07	1.9e-05	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism—PTEN—kidney cancer	4.78e-07	1.84e-05	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—POMC—kidney cancer	4.78e-07	1.84e-05	CbGpPWpGaD
Fluorouracil—ALB—Metabolism—PTEN—kidney cancer	4.75e-07	1.83e-05	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—PTGS2—kidney cancer	4.46e-07	1.71e-05	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—PTEN—kidney cancer	3.89e-07	1.49e-05	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—PTGS2—kidney cancer	3.81e-07	1.46e-05	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism—PIK3CA—kidney cancer	3.37e-07	1.3e-05	CbGpPWpGaD
Fluorouracil—ALB—Metabolism—PIK3CA—kidney cancer	3.35e-07	1.29e-05	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—PTEN—kidney cancer	3.32e-07	1.28e-05	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—PIK3CA—kidney cancer	2.74e-07	1.05e-05	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—PIK3CA—kidney cancer	2.34e-07	9.01e-06	CbGpPWpGaD
